LONDON/MUMBAI (Reuters) - India's Ranbaxy Laboratories has tentative U.S. approval to sell a generic form of AstraZeneca's blockbuster heartburn and ulcer pill Nexium, damaging confidence in the Anglo ...

LONDON (Reuters) - Generic competition to AstraZeneca's top-selling acid reflux drug Nexium moved a step closer in Canada, after a court rejected the drugmaker's bid to stop a copycat version from ...

CHICAGO -- U.S. employers, struggling to tame double-digit health inflation, are putting the squeeze on AstraZeneca's ulcer drug Nexium, a product the Anglo-Swedish drug maker sorely needs to boost ...

TRENTON, N.J. (AP) -- Drugmakers AstraZeneca PLC and Pfizer Inc. have reached a deal giving Pfizer future rights to sell a nonprescription version of AstraZeneca's blockbuster heartburn drug, Nexium, ...

Teva subsidiary Ivax gets approval to market a generic Nexium product for treating acid reflux disease. The Food and Drug Administration approved the first generic version of Nexium, AstraZeneca's ...

Will the FDA ever allow Ranbaxy Laboratories to sell a generic version of the Nexium heartburn pill? The Connecticut attorney general wants to know what is taking the agency so long, because Ranbaxy ...

The FDA approved the first generic version of Nexium — esomeprazole magnesium delayed-release capsules — to treat gastroesophageal reflux disease. Esomeprazole is a proton pump inhibitor that reduces ...